Omar Ishrak insider trades

Open-market stock purchases and sales by Omar Ishrak, Director at Amgen Inc, from SEC Form 4 filings since Jun 13, 2011.

Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +122%.

Recent trades

DateStockTradeValue
Aug 7, 2026AMGN Amgen IncBought (not open market)—
May 19, 2026AMGN Amgen IncBought (not open market)—
May 5, 2026AMGN Amgen IncBought (not open market)—
Nov 7, 2025AMGN Amgen IncBought (not open market)—

Companies traded

  • AMGN Amgen Inc: other filings, last Aug 7, 2026
  • INTC Intel Corp: 3 buys, last Mar 28, 2025
  • ALUR Allurion Technologies, Inc: other filings, last Oct 23, 2023
  • MDT Medtronic plc: 1 buy, 12 sales, last Oct 15, 2020

Get free alerts when Omar Ishrak files a new trade →